Page last updated: 2024-10-26

valproic acid and Tumor Lysis Syndrome

valproic acid has been researched along with Tumor Lysis Syndrome in 1 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Tumor Lysis Syndrome: A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Radaelli, E1
Marchesi, F1
Patton, V1
Scanziani, E1

Other Studies

1 other study available for valproic acid and Tumor Lysis Syndrome

ArticleYear
Diagnostic exercise: sudden death in a mouse with experimentally induced acute myeloid leukemia.
    Veterinary pathology, 2009, Volume: 46, Issue:6

    Topics: Acute Disease; Animals; Antineoplastic Agents; Death, Sudden; Disease Models, Animal; Female; Leukem

2009